Gara Jalqabaatti › Leukemia Myeloidii Hamaa › California › Baldwin Park
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Baldwin Park, CA keessatti
Qorannoo 40 Leukemia Myeloidii Hamaa f Baldwin Park fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 2/3
- City of Hope National Medical Center /ID# 279568, Duarte · Miili 4 fagaatti
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Clinical Trial Site, Duarte · Miili 4 fagaatti
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 3
- City of Hope, Duarte · Miili 4 fagaatti
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Namoota walitti qabaa jiraSadarkaa 3
- City of Hope Comprehensive Cancer Center, Duarte · Miili 4 fagaatti
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Namoota walitti qabaa jiraSadarkaa 2
- City of Hope Comprehensive Cancer Center, Duarte · Miili 4 fagaatti
Phase 1 Study of AUTX-703 in Relapsed/Refractory AML and MDS
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope National Medical Center, Duarte · Miili 4 fagaatti
The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 1/2Hojjettoota fayyaa simatamoo
- City of Hope, Duarte · Miili 4 fagaatti
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 1/2
- City of Hope Comprehensive Cancer Center, Duarte · Miili 4 fagaatti
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1/2
- City of Hope National Medical Center, Duarte · Miili 4 fagaatti
MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
8-Chloroadenosine in Combination With Venetoclax for the Treatment of Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Individualized AML Treatment
Namoota walitti qabaa jiraQorannoo ilaalaa
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Namoota walitti qabaa jiraSadarkaa 3
- City of Hope Comprehensive Cancer Center - Duarte, Duarte · Miili 4 fagaatti
Tagraxofusp and Azacitidine for Maintenance Treatment in Patients With CD123 Positive AML and MDS Following Donor Hematopoietic Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- City of Hope, Duarte · Miili 4 fagaatti
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Namoota walitti qabaa jiraSadarkaa 2
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
A Study of Revumenib and Mezigdomide in People With Leukemia
Namoota walitti qabaa jiraSadarkaa 1/2
- City of Hope Cancer Center (Data collection only), Duarte · Miili 4 fagaatti
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1Hojjettoota fayyaa simatamoo
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Namoota walitti qabaa jiraSadarkaa 2
- City of Hope, Duarte · Miili 4 fagaatti
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 2Hojjettoota fayyaa simatamoo
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Olutasidenib for the Treatment of Patients With IDH1 Mutated AML, MDS or CMML After Donor Hematopoietic Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Center (City of Hope National Medical Center, City of Hope Medical Center), Duarte · Miili 4 fagaatti
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope - Duarte, Duarte · Miili 4 fagaatti
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope Medical Center, Duarte · Miili 4 fagaatti
Study of REM-422 in Patients With AML or Higher Risk MDS
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope, Duarte · Miili 4 fagaatti
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- City of Hope National Medical Center, Duarte · Miili 4 fagaatti
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Seattle, WAQorannoo 41
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 31
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
- Washington, DCQorannoo 24
Qorannoo biroo Baldwin Park keessatti
- Saree OljooQorannoo 44
- Kansarii ColorectalQorannoo 37
- Kansara Qara'a Non-Small CellQorannoo 36
- Saree (Gosoota Hunda)Qorannoo 34
- Kansarii ProstateQorannoo 30
- Kansara MetastatikiiQorannoo 30
- Myelodysplastic SyndromesQorannoo 26
- Kansarii OvariiQorannoo 25
- Dhibee QaraQorannoo 24
- Myeloma Baay’eeQorannoo 23
- Kanisa HarkaaQorannoo 22
- Leukemia Lymphoblasticii HamaaQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.